Abstract:The aim of the study. The aim of the work was to investigate in vivo anticancer activity of cis- and trans-diadamanthylcarboxylates of dirhenium(III) alone and together with cisplatin in form of nanobins.Materials and methods. Model of tumor growth, Guerin’s carcinoma; intraperitoneal administration of cisplatin, dirhenium(III) compounds in liposomes and of binary liposomes, containing both cytostatics; volumes and final weights of tumors were measured.Results. In vivo antitumor properties of two dirhenium(III… Show more
“…12 Icsel et al, also reported novel platinum bases complexes whose cis-congeners showed more activity than those of the trans. 13 The in vivo anticancer properties of rhenium complexes reported by Shtemenko et al, 14 also revealed that the cis-analogue is slightly more active than the trans-analogue. Several factors are reported to be responsible for this activity; the cis-isomers are found to be less stable and lower in energy compared to the trans-isomers; 15 hence, making it easy for the leaving group to be cleaved and subsequently bind to the DNA.…”
“…12 Icsel et al, also reported novel platinum bases complexes whose cis-congeners showed more activity than those of the trans. 13 The in vivo anticancer properties of rhenium complexes reported by Shtemenko et al, 14 also revealed that the cis-analogue is slightly more active than the trans-analogue. Several factors are reported to be responsible for this activity; the cis-isomers are found to be less stable and lower in energy compared to the trans-isomers; 15 hence, making it easy for the leaving group to be cleaved and subsequently bind to the DNA.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.